End-of-day quote
Other stock markets
|
||
- SEK | - |
05-15 | SenzaGen AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
03-25 | Senzagen Receives Follow-Up Order Worth SEK 0.8 Million from the Global Chemicals Leader | CI |
Business Summary
Sales per Business
SEK in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Genomic Allergen Rapid Detection
100.0
%
| 42 | 100.0 % | 50 | 100.0 % | +19.39% |
Sales per region
SEK in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Sweden
100.0
%
| 42 | 100.0 % | 50 | 100.0 % | +19.39% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Peter Nählstedt
CEO | Chief Executive Officer | 50 | 31/12/17 |
Marianne Olsson
DFI | Director of Finance/CFO | 63 | 31/10/16 |
Henrik Johansson
CTO | Chief Tech/Sci/R&D Officer | 42 | 31/12/13 |
Director/Board Member | 59 | 14/10/14 | |
Public Communications Contact | 56 | 31/12/17 | |
Helen Olsson
HRO | Human Resources Officer | 59 | 31/12/19 |
Corporate Officer/Principal | 51 | 31/12/16 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Founder | 76 | 17/08/10 | |
Director/Board Member | 59 | 14/10/14 | |
Paula Zeilon
BRD | Director/Board Member | 62 | 31/12/19 |
Director/Board Member | 65 | 31/12/19 | |
Peter Nählstedt
CEO | Chief Executive Officer | 50 | 31/12/17 |
Ian Kimber
BRD | Director/Board Member | 74 | 31/12/14 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 24,188,325 | 14,889,392 ( 61.56 %) | 0 | 61.56 % |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
-31.90% | 9.59B | |
-6.25% | 3.21B | |
+25.95% | 2.92B | |
-13.96% | 2.15B | |
-16.83% | 1.79B | |
+72.82% | 1.47B | |
+29.17% | 770M | |
-2.62% | 761M | |
-26.33% | 548M |
- Stock Market
- Equities
- SENZA Stock
- Stock
- Company SenzaGen AB